Navigation Links
BiphedAdrene™, Complex Phenylethylamine Provisional Plus Aggressive Thermogenic Compound, Leads Super-Powerful "Diet Pill" Comeback
Date:1/3/2012

SALT LAKE CITY, Jan. 3, 2012 /PRNewswire/ -- When the FDA removed Fen-Phen from the U.S. market in 1997 and Ephedra in 2004, U.S. consumers believed that powerful diet pills had become a thing of the past. Instead a huge, "underground," multi-billion-dollar market for amphetamine-like fat burners sprung up almost immediately, and it wasn't long before these types of products started quietly showing up in gym bags and medicine cabinets.

Demand for these "go-fast" pills has risen to such levels that local retailers like Wal-Mart, Walgreen's, and GNC are now carrying the high-quality, extremely effective versions of them, and leading the pack is Generix Labs™ newest product, BiphedAdrene™.

BiphedAdrene is a two-part system comprised of a unique "Complex Phenylethylamine Provisional" (for powerful appetite control, mood-elevation, and energy) and an aggressive thermogenic compound (for fat burning and stamina). Clearly created for consumers seeking successful weight loss and body fat reduction, this product is also attracting a new clientele: college students, fitness enthusiasts... even overstressed, exhausted homemakers who are all looking for something that can give them increased energy and a boost in stamina.

"Super pills" like BiphedAdrene are becoming hugely popular, but they're not for everyone. Because of the nature of their highly effective compounds, they were designed specifically for the significantly overweight... not those who just need to lose 5 or 6 "vanity pounds." And they should only be taken by those who are in overall good health, so check with your doctor before trying one of these super-powerful "diet pills."

If you want to try BiphedAdrene, check your local GNC or Wal-Mart. You can also order it directly from Generix Labs by visiting www.BiPhed.com.

And here's an inside tip: If you order from Generix Labs, make sure to use promo code INSTOCK. Why? Demand for BiphedAdrene has been so high the company has had difficulty keeping it in stock. As a way to apologize to customers who've been waiting to get their hands on a box, Generix is offering a $25 discount when you use that code. (Note: The INSTOCK promo code was still valid as of January 2, 2012.)

 

 

 


'/>"/>
SOURCE BiphedAdrene
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
2. Franklin & Seidelmann Publishes Complex Podiatry MRI Study
3. Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders
4. SCAI: CARDia Data Find Diabetic Patients With Complex Heart Disease Can Safely Choose PCI
5. SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease
6. SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery
7. Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized Moderate Complexity by FDA
8. SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease
9. Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients
10. SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease
11. CardioVascularCS.Org, a division of EndoVascular Forum, Inc., Partners with Complex Interventional Cardiovascular Therapy (CICT) to Extend Electronic Medical Care Advancement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Dec. 6, 2016 The pen needles market ... from USD 1.65 billion in 2016, growing at a ... to 2021. Over the years, the pen needles ... cater to the growing demand for safety injections in ... development of safety pen needles with an aim to ...
(Date:12/6/2016)... , Dec. 6, 2016   AlloSource ... cartilage, cellular, bone, skin and soft-tissue allografts for ... , Business Process Manager, for being named to ... Baldrige National Quality Award by the Commerce Department,s ... the organization,s commitment to process excellence. The Baldrige ...
(Date:12/6/2016)... 6, 2016  Nearly 30 million people in ... epidemic of diabetes. 1 However, nearly 40% of ... levels (hyperglycemia) and significant glucose variability. 2 These patients ... cardiovascular events. If left untreated, hyperglycemia can lead to ... or blindness. 3 As part of ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... , ... “Tomorrow Trump Goes To Washington”: a brief but engaging illustration ... to America. “Tomorrow Trump Goes To Washington” is the creation of published author, Nancy ... country. , Nancy attributes her patriotic nature to her WWII veteran father. She ...
(Date:12/7/2016)... ... 2016 , ... Dr. Greg Leyer, the Chief Scientific Officer ... DC workshop on November 2nd. The conference was an opportunity for both probiotic ... regulations. , Dr. Leyer spoke about two main topics at the IPA ...
(Date:12/6/2016)... ... December 06, 2016 , ... Men with gum disease ... of serious health problems, such as cardiovascular illness, according to research cited in ... Hills Periodontics & Dental Implant Center notes that the correlation between periodontal disease ...
(Date:12/6/2016)... TX (PRWEB) , ... December ... ... in predictive and prescriptive health insights for population health management, announces today ... provider. VitreosHealth will leverage CitiusTech’s cloud-hosted clinical rules engine that offers advanced ...
(Date:12/6/2016)... ON (PRWEB) , ... December 06, 2016 , ... CarriersEdge, ... today announced a new suite of Driver Wellness courses. Offered in three modules, the ... a starting point so fleets can educate drivers about how to stay healthy on ...
Breaking Medicine News(10 mins):